News

Daiichi Sankyo has presented results of the study at the 21st International Congress on Thrombosis (ICT) in Milan, Italy. Daiichi Sankyo’s Phase III STARS E-3 study, in Japan

The trial trial was designed to determine if preoperative administration of NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel (AC-T) results in at least a doubling

Caldolor study was a double-blind, placebo-controlled malaria trial that evaluated 60 adults with acute uncomplicated falciparum malaria who were treated with artemisinin combination therapy. In the study, patients

As per the terms of the agreement, with this two year extension, Galapagos is expected to be eligible to receive up to $8.6m. BioFocus runs a compound management

The extremolyte Ectoin (1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid) is a cyclic amino acid that is produced mainly by halophilic bacteria to protect the cells from the extreme osmotic stress associated with

The survivin protein is believed to be important in the growth and survival of cancer cells and is over-expressed in common cancers, such as melanoma, prostate, pancreatic, colorectal

Protalix BioTherapeutics said that the FDA has granted taliglucerase alfa a standard review time of 10 months, assigning a prescription drug user fee act (PDUFA) action date of

Mr Hockins has over 15 years of management experience in sales and marketing in the pharmaceutical, life sciences and in-vitro diagnostics sectors. He held various positions including director

Previously, Dr Kelly has served for Boehringer Ingelheim for nearly 20 years, most recently as vice president of Chemistry. Boehringer Ingelheim, develops and manufactures biopharmaceuticals by offering the